Purpose: The etiology, pathophysiology, prognostic factors, pharmacologic treatment, and pharmacoeconomic considerations of nonvariceal upper-gastrointestinal-tract bleeding (UGB) are reviewed.
A study published in The Lancet examined celecoxib use versus naproxen in patients with cardiothrombotic diseases and arthritis. Francis K. L. Chan, MD, of the Chinese University of Hong Kong, and ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved an oral suspension omeprazole and sodium bicarbonate for the treatment of active benign ...
Gastrointestinal bleeding in GIST patients significantly impacts recurrence-free and overall survival, with gastric bleeding linked to worse prognosis. Bleeding is less common in the small intestine, ...
Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution. The Food and Drug Administration (FDA) has approved Konvomep ™ (omeprazole and ...
Health on MSN
What causes a gastrointestinal (GI) bleed?
Symptoms of GI bleeding include stomach pain, vomiting blood, or having black, tarry stool. Peptic ulcers are the leading ...
ALBANY, N.Y, Oct. 15, 2020 /PRNewswire/ -- Set to chart a compound annual growth rate of 4.5% from 2018 to 2026, the global gastrointestinal bleeding treatment market is witnessing creation of a host ...
Researchers have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning ...
DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Bleeding Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026" report has been added to ...
Both conditions involve symptoms of gastrointestinal bleeding, though a major difference is that hematochezia often presents as bright red blood in the stool, while melena appears as black, tarry ...
a Unless otherwise noted, endoscopic treatment was performed. b When two figures are given, the first is for the omeprazole group and the second is for the placebo group. Unless otherwise noted, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results